bioAffinity Technologies Inc. Warrant is a biotechnology company that specializes in the development of diagnostic tests for early detection of cancer and other diseases. Their innovative technology offers a promising solution to the global healthcare challenge, providing accurate and affordable screening tools for improved patient outcomes. With a strong focus on research and development, bioAffinity Technologies is poised to revolutionize the world of medical diagnostics.
